PROPHYLACTIC OR THERAPEUTIC AGENT FOR KERATOCONJUNCTIVAL DISORDER COMPRISING QUINAZOLINONE DERIVATIVE OR QUINOXALINE DERIVATIVE AS ACTIVE INGREDIENT

摘要

PPROBLEM TO BE SOLVED: To provide a new prophylactic or therapeutic agent for keratoconjunctive disorder. PSOLUTION: The compound represented by general formula (I) or salts thereof exhibits excellent prophylactic and therapeutic effect to keratoconjunctive disorder or the like developing with aging, as an agent in the pharmacological test using SAMP 10 and so they are useful as a prophylactic or therapeutic agent for keratoconjunctive disorders such as dry eye, superficial punctate keratopathy, or keratoconjunctive disorder such as corneal epithelial defect. In the general formula (I), ASB1/SB-ASB2/SBmeans formula (). PCOPYRIGHT: (C)2009,JPO&INPIT